Literature DB >> 15994365

Autonomy, consent, and limiting healthcare costs.

M A Graber1, J F Tansey.   

Abstract

While protection of autonomy is crucial to the practice of medicine, there is the persistent risk of a disconnect between the notion of self-determination and the need for a socially responsible medical system. An example of unbridled autonomy is the preferential use of costly medications without an appreciation of the impact of using these more expensive drugs on the resource pool of others. In the USA, costly medications of questionable incremental benefit are frequently prescribed with the complicity of both doctors and patients. Limiting self-determination in medication choices via an appreciation of the principle of justice reaches a better moral balance, while at the same time acknowledging the goals of doing good and avoiding harm in patient care.

Entities:  

Keywords:  Health Care and Public Health

Mesh:

Year:  2005        PMID: 15994365      PMCID: PMC1734188          DOI: 10.1136/jme.2003.003574

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  21 in total

1.  The educational value of consumer-targeted prescription drug print advertising.

Authors:  R A Bell; M S Wilkes; R L Kravitz
Journal:  J Fam Pract       Date:  2000-12       Impact factor: 0.493

2.  Timing of new black box warnings and withdrawals for prescription medications.

Authors:  Karen E Lasser; Paul D Allen; Steffie J Woolhandler; David U Himmelstein; Sidney M Wolfe; David H Bor
Journal:  JAMA       Date:  2002-05-01       Impact factor: 56.272

3.  Why are thiazide diuretics declining in popularity?

Authors:  D G Beevers; R E Ferner
Journal:  J Hum Hypertens       Date:  2001-05       Impact factor: 3.012

4.  Addressing the problem of misleading advertising.

Authors:  D A Kessler
Journal:  Ann Intern Med       Date:  1992-06-01       Impact factor: 25.391

5.  Drug companies' evidence to justify advertising.

Authors:  V A Wade; P R Mansfield; P J McDonald
Journal:  Lancet       Date:  1989-11-25       Impact factor: 79.321

6.  Which medicines do our patients want from us?

Authors:  M P Schwartz; P J Wagner
Journal:  J Fam Pract       Date:  2000-04       Impact factor: 0.493

7.  The accuracy of drug information from pharmaceutical sales representatives.

Authors:  M G Ziegler; P Lew; B C Singer
Journal:  JAMA       Date:  1995-04-26       Impact factor: 56.272

8.  Physician awareness of prescription drug costs: a missing element of drug advertising and promotion.

Authors:  L G Miller; A Blum
Journal:  J Fam Pract       Date:  1993-01       Impact factor: 0.493

Review 9.  Characteristics of materials distributed by drug companies. An evaluation of appropriateness.

Authors:  D Stryer; L A Bero
Journal:  J Gen Intern Med       Date:  1996-10       Impact factor: 5.128

10.  Choosing between apples and apples: physicians' choices of prescription drugs that have similar side effects and efficacies.

Authors:  K T Safavi; R A Hayward
Journal:  J Gen Intern Med       Date:  1992 Jan-Feb       Impact factor: 5.128

View more
  2 in total

1.  Changes in attitudes towards hastened death among Finnish physicians over the past sixteen years.

Authors:  Reetta P Piili; Riina Metsänoja; Heikki Hinkka; Pirkko-Liisa I Kellokumpu-Lehtinen; Juho T Lehto
Journal:  BMC Med Ethics       Date:  2018-05-30       Impact factor: 2.652

2.  Premature consent and patient duties.

Authors:  Andrew P Rebera; Dimitris Dimitriou
Journal:  Med Health Care Philos       Date:  2021-05-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.